Plain-English translation of NCT07216157 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether using special sealants during nasal skull base surgery—specifically Tisseel (a biological glue) or Adherus (a synthetic polymer)—actually prevents cerebrospinal fluid leaks better than standard surgical closure alone. Right now, surgeons use these sealants routinely, but recent evidence suggests they may not be necessary for all patients, especially those at low risk. This study will help determine which approach works best and is most cost-effective.
Cerebrospinal fluid leaks are a common and serious complication after nasal skull surgery, and surgeons have started using expensive sealants to prevent them. However, recent high-quality research questions whether these products actually improve outcomes, especially for patients who are already at low risk for leaks. This trial will provide clear evidence to guide better, more cost-effective surgical practices.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to one of three surgical approaches: standard closure only, standard closure plus Tisseel sealant, or standard closure plus Adherus sealant. You will have your surgery performed as assigned, and then return for follow-up visits at 6 weeks and 3 months after surgery. During these visits, your surgeon will check your surgical wound healing with an endoscope (a small camera) and monitor you for any complications like fluid leaks or infection. The study will last approximately 3 months from the time of your surgery.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Poland